Verastem (VSTM) Return on Sales (2018 - 2026)
Verastem's quarterly Return on Sales came in at 0.02% in Q1 2026, down 148.39% quarter-over-quarter from 0.05% in Q4 2025.
Verastem has reported Return on Sales for 8 years, with the latest figure at 0.02% in Q1 2026.
- For the quarter ending Q1 2026, Return on Sales changed N/A year-over-year to 0.02%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (changed N/A YoY), and the FY2025 full-year result was 0.07%, up 6.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.02%, down from 0.05% in the prior quarter.
- The five-year high for Return on Sales was 0.05% in Q4 2025, with the low at 0.28% in Q4 2022.
- Average Return on Sales over 4 years is 0.12%, with a median of 0.11% recorded in 2024.
- Year-over-year, Return on Sales soared 11370 bps in 2022 and slipped 18 bps in 2025.
- Tracing VSTM's Return on Sales over 4 years: stood at 0.28% in 2022, then soared by 59 bps to 0.12% in 2024, then jumped by 142 bps to 0.05% in 2025, then sank by 148 bps to 0.02% in 2026.
- The last three Return on Sales figures came in at 0.02% (Q1 2026), 0.05% (Q4 2025), and 0.04% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 0.00% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.00% |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.02% |
| Dec 31, 2025 | 0.05% |
| Sep 30, 2025 | -0.04% |
| Jun 30, 2025 | -0.20% |
| Dec 31, 2024 | -0.12% |
| Sep 30, 2024 | -0.11% |
| Jun 30, 2024 | -0.02% |
| Dec 31, 2022 | -0.28% |
| Sep 30, 2022 | -0.23% |
| Jun 30, 2022 | -0.25% |
| Mar 31, 2022 | -0.07% |
| Dec 31, 2021 | -0.30% |
| Sep 30, 2021 | -113.93% |
| Jun 30, 2021 | -0.34% |
| Mar 31, 2021 | -0.15% |
| Dec 31, 2020 | -0.39% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | -0.05% |
| Mar 31, 2020 | -0.08% |
| Dec 31, 2019 | -0.11% |
| Sep 30, 2019 | -0.03% |
| Jun 30, 2019 | -0.13% |
| Mar 31, 2019 | -0.23% |
| Dec 31, 2018 | -0.31% |
| Sep 30, 2018 | -0.01% |
| Jun 30, 2018 | -0.02% |